Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2010
02/24/2010CN100591774C Process for manufacture of nematode-extracted anticoagulant protein (NAP)
02/24/2010CN100591770C Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
02/24/2010CN100591762C Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/24/2010CN100591758C Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins
02/24/2010CN100591692C Pig fat deposition related protein and encoding genes and use thereof
02/24/2010CN100591691C Anti-tumour compound
02/24/2010CN100591686C CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
02/24/2010CN100591359C Lentiviral vector-mediated gene transfer and uses thereof
02/23/2010US7667100 Expression vector comprising nucleotide sequences coding which confer a tolerant phenotype in plants in response to chronic and/or acute inhibitin dosages of auxinic herbicides
02/23/2010US7667099 Comprises expression vectors coding accumulation and replication of chloroplast (ARC) polypeptides for altering size, morphhology and number of plastids in crop plants
02/23/2010US7667097 Rice pollen-preferential promoters and uses thereof
02/23/2010US7667092 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
02/23/2010US7667089 mice, rats, goats, pigs, sheep and cows, whose genome comprises alpha-lactalbumin promoter
02/23/2010US7667088 bioassay; induction of antibodies against desmoglein; activation of lymphocytes; oral diseases
02/23/2010US7667022 Antitubercular agents; expression systems; effective under changing conditions
02/23/2010US7667020 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease; treat, prevent, or delay a tissue proliferation-associated disorder as rheumatoid arthritis and multiple sclerosis
02/23/2010US7667019 Flea ultraspiracle nucleic acid molecules
02/23/2010US7667018 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response
02/23/2010US7667016 nucleic acid compositions encoding a unique colorless protein, can be photoactivated, used in many biochemical, molecular biological and medical diagnostic applications
02/23/2010US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer
02/23/2010US7667013 Gene encoding a guanine nucleotide exchange factor and the gene product thereof
02/23/2010US7667009 Isolating dermatophagoides protein via anion exchange and hydrophobic gel adsorption
02/23/2010US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent
02/23/2010US7667005 Polypeptide, novel DNA and novel antibody
02/23/2010US7667003 Antibody directed to human mist (mast cell immunoreceptor signal transducer)
02/23/2010US7667002 Peptides and proteins for early liver development and antibodies thereto
02/23/2010US7667000 Antibodies to Zcytor 16
02/23/2010US7666999 Neutral amino acid transporter and gene thereof
02/23/2010US7666997 Antitumor agents
02/23/2010US7666995 Interferons, uses and compositions related thereto
02/23/2010US7666994 fusion protein comprising isolated GnRH receptor protein; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment
02/23/2010US7666993 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines
02/23/2010US7666992 Pancreatic cancer genes
02/23/2010US7666991 Compositions for needleless delivery of antibodies
02/23/2010US7666990 reduce blood clotting activity by reducing thrombin generation; thrombotic diseases
02/23/2010US7666989 Polynucleotide encoding the amino acid sequence; DNA sequence which encodes a protein; expression vector gene; cell line; multiple myeloma, leukemia, brain glioma, lung cancer and colon cancer
02/23/2010US7666988 BASB082 Polypeptides
02/23/2010US7666987 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis
02/23/2010US7666985 HLA-A24-restricted cancer antigen peptides
02/23/2010US7666984 Consisting of the amino acid sequence ALFDGDPHL, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases
02/23/2010US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants
02/23/2010US7666982 extracellular markers whereby Notch signal transduction can be detected; these peptides (N beta ) are released from cells in proportion to Notch signal depending on presenilin; by detecting these peptides, Notch signal transduction, cell differentiation, apoptosis, Alzheimer's disease can be detected
02/23/2010US7666981 Inhibitors of prostasin
02/23/2010US7666980 Calcium-binding photoprotein, gene encoding the same, and use thereof
02/23/2010US7666849 Ribosome structure and protein synthesis inhibitors
02/23/2010US7666842 Elastin peptide analogs and uses thereof
02/23/2010US7666840 α-Conotoxin peptides
02/23/2010US7666839 Methods of treatment using specific binding agents of human angiopoietin-2
02/23/2010US7666838 Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes
02/23/2010US7666837 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
02/23/2010US7666835 oxyntomodulin a polypeptide is administered to a obese mammal by oral, parenteral, mucosal, rectal subcutaneous or transdermal administration
02/23/2010US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent
02/23/2010US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent
02/23/2010US7666678 Proteins imparting boron-tolerance and genes thereof
02/23/2010US7666670 Animal model for the fast identification of pharmaceutical active compounds in vivo
02/23/2010US7666669 Polypeptide
02/23/2010US7666655 Escherichia bacteria transformed with the yddG gene to enhance L-amino acid producing activity
02/23/2010US7666648 Isolated polypeptide having arabinofuranosidase activity
02/23/2010US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
02/23/2010US7666634 Fermentation process for the preparation of L-amino acid using modified Escherichia coli wherein the ytfP-yjfA gene region is inactivated
02/23/2010US7666628 Preparation of heterologous proteins on oil bodies
02/23/2010US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi)
02/23/2010US7666625 Methods for producing biological substances in pigment-deficient mutants of bacillus cells
02/23/2010US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response
02/23/2010US7666622 Nucleic acid encoding monomeric fusion polypeptide R1-M-L-M, wherein R1 is a ligand-binding domain of an interleukin receptor capable of binding an interleukin target ligand, M is a self-associating component, and L is a linker; therapy for cancer or diabetic retinopathy
02/23/2010US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D
02/23/2010US7666619 Compounds and methods for regulating bacterial growth and pathogenesis
02/23/2010US7666612 Methods for protein labeling based on acyl carrier protein
02/23/2010US7666611 Lysophosphatidic acid receptor
02/23/2010US7666610 Expressing transporters on viral envelopes
02/23/2010US7666608 Determining ratio of expression levels of serum amyloid A1 (SAA1) gene and serum amyloid A2 (SAA2) gene; steroid treatment prognosis; tumor necrosis factor inhibitors
02/23/2010US7666607 tumor necrosis factor receptors; drug screening modulators of jun n-terminal kinase and nuclear factor kappa beta
02/23/2010US7666603 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
02/23/2010US7666601 Membrane protein; point mutations; antibodies; food processing and bitterness; phenotype analysis
02/23/2010US7666595 Biomarkers for predicting prostate cancer progression
02/23/2010US7666591 Single stranded DNA binding proteins from Archaea and uses therefor
02/23/2010US7666586 Such as urinary bladder tissue; immunoassays
02/23/2010US7666582 Immunoglobulin G-degrading enzyme for use as tool in diagnosis, prevention and treatment of streptococcal infection
02/23/2010US7666581 Complexing antigenic proteins/peptides; membrane proteins; tumor associated antigens
02/23/2010US7666441 Nucleic acids encoding peptides having at least one biological activity of Can f I or Can f II, protein allergens of the species Canis familiaris; suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander
02/23/2010US7666436 Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
02/23/2010US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides
02/23/2010US7666432 Suppressing fibrosis in a mammal having a fibrosing disease by administering a Serum Amyloid P (SAP) protein; treatment of diseases such as scleroderma, pulmonary fibrosis and asthma
02/23/2010US7666431 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
02/23/2010US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
02/23/2010US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor
02/23/2010US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity
02/23/2010US7666427 Plasmid DNA or viral vector vaccine including components from different clades of Env and Gag-Pol-Nef from a single clade; multiclade HIV envelope immunogen
02/23/2010US7666416 Mammalian cell culture process
02/23/2010US7666412 Methods for the treatment of neoplastic disorders with anti-caveolin agents
02/23/2010US7666405 Deleted adenovirus vectors and methods of making and administering the same
02/23/2010US7666404 Glanders/meliodosis vaccines
02/23/2010US7666403 Mutant interferon α protein and use thereof
02/23/2010US7666402 Use of IL-22 for the treatment of conditions of metabolic disorders
02/23/2010US7666401 Compositions comprising a ligand of Chemerin R
02/23/2010US7666400 PEGylation by the dock and lock (DNL) technique
02/23/2010CA2469630C Enhanced oil seed protein recovery
02/23/2010CA2428641C Functional fragment of the leptin receptor
02/23/2010CA2416949C Non-human animal model unresponsive to mycoplasma derived lipoprotein/lipopeptide
02/23/2010CA2389743C Recombinant sendai virus vector for introducing exogenous genes to airway epithelia